TMC207 for treatment of people with pulmonary tuberculosis

  • Protocol
  • Intervention

Authors

  • Bruno Rosa,

    Corresponding author
    1. Universidade Federal do Rio de Janeiro, Instituto de Estudos em Saúde Coletiva, Rio de Janeiro, Rio de Janeiro, Brazil
    • Bruno Rosa, Instituto de Estudos em Saúde Coletiva, Universidade Federal do Rio de Janeiro, Praça Jorge Machado Moreira, 100, Rio de Janeiro, Rio de Janeiro, 21941-598, Brazil. brunofisioterapia@gmail.com.

    Search for more papers by this author
  • Valeria Cavalcanti Rolla,

    1. Fundação Oswaldo Cruz, Instituto de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil
    Search for more papers by this author
  • Antonio JL Alves da Cunha,

    1. School of Medicine, Federal University of Rio de Janeiro, Department of Pediatrics, Rio de Janeiro, Rio de Janeiro, Brazil
    Search for more papers by this author
  • Renato Fernandes de Paulo,

    1. Universidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Rio de Janeiro, Brazil
    Search for more papers by this author
  • Roberto A Medronho,

    1. Universidade Federal do Rio de Janeiro, Instituto de Estudos em Saúde Coletiva, Rio de Janeiro, Rio de Janeiro, Brazil
    Search for more papers by this author
  • Álvaro N Atallah

    1. Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effectiveness and safety of TMC207 as a substitute or additional drug for treatment of drug-sensitive and MDR-TB.